( Rosetta Genomics Ltd a leading microRN...)Role of MicroRNA in Cancer Suppression Identified,Health

Rosetta Genomics Ltd, a leading microRNA company, announced today research published in the journal Molecular Cell by scientists from the Weizmann Institute of Science and Rosetta Genomics . The findings suggest the potential for a specific, single microRNA (miR-34a) to be used as a drug candidate in cancer therapy to increase programmed cell-death (apoptosis) in the context of the potent tumor suppressor p53.

p53 has been widely accepted as a powerful tumor inhibitor that can prevent or slow the spread of cancer cells by facilitating apoptosis. In this study, activation of p53 in-vivo in mice as well as in cultured human cells induced the expression of a specific microRNA (miR-34a). Based on the likelihood that miR-34a could itself play a role in cellular apoptosis, researchers introduced miR-34a directly into human cancer cell lines to determine its impact on tumor cell behavior. The results clearly demonstrated that overexpression of miR-34a led to increased cancer cell death as well as promoted other important anti-proliferative activities. The ability of miR-34a to promote apoptosis of cancer cells makes it an attractive candidate tumor suppressor. The data presented in Molecular Cell is also supported by recent studies (Gaur et at., 2007, Welch et al. 2007) showing that miR-34a is under-expressed in central nervous system tumors.

"This is a groundbreaking study shedding light on the critical role microRNAs play in fighting cancer and highlights their potential to act as novel drug targets", noted Dr. Dalia Cohen, Global Head of Research and Development at Rosetta Genomics. "By introducing increased amounts of miR-34a into the cell-lines, Rosetta Genomics researchers and the world class team at Weizmann Institute have been able to show that the overexpression of this specific microRNA is directly linked to tumor suppression. Moreover, the results suggest the potential that a synthetic miR-34a-like agent could be used as a cancer ther
'"/>




Page: 1 2
Related medicine news :

1. MicroRNA provides new insight into birth defects
2. Role Of MicroRNAs In Angiogenesis Researched
3. Pair of MicroRNA Molecules Controls Major Oncogene in Most Common Leukemia
4. MicroRNAs Can Be Tumor Suppressors
5. Fibroids unlikely to Turn Cancerous
6. Virus Level could Predict Cervical Cancer Risk
7. Cancer Doctors Okays Controversial Prostate Therapy
8. Potential New Cancer Gene Identified
9. Consensus on "Combination Therapy" for Breast Cancer
10. Cancers of Colon & Rectum linked to Cigarette Smoking
11. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos